News about RPID

White Brook Capital's Q3 2026 investor letter highlights Rapid Micro Biosystems (NASDAQ:RPID), a life sciences firm providing automated microbial detection and quality control for biopharmaceutical manufacturing. The stock closed at $0.82 on October 21, 2026, with a $40.94 million market cap, down 71.86% year to date and trading in a 52-week range of $0.76 to $4.94. White Brook says the business has strengthened, margin targets have been met, and the MilliporeSigma relationship is on track. However, the share price has suffered from an ill-conceived equity issuance and concerns that more could follow. The firm believes the share price implies a more pessimistic outlook for next year's cash use than is likely.